发布求助
文献互助 智能选刊 最新文献

C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD最新文献

筛选
英文 中文
Efficacy and Safety of Mepolizumab as an Add-on Therapy in Chinese Patients With Severe Eosinophilic Asthma: A Randomized, Double-Blind, Parallel Group Phase 3 Study Mepolizumab作为中国重度嗜酸性粒细胞哮喘患者附加治疗的有效性和安全性:一项随机、双盲、平行组3期研究
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4766
R. Chen, L. Wei, Y. Dai, Z. Wang, D. Yang, M. Jin, C. Xiong, T. Li, S. Hu, J. Song, N. Day, R. Chan, N. Zhong
{"title":"Efficacy and Safety of Mepolizumab as an Add-on Therapy in Chinese Patients With Severe Eosinophilic Asthma: A Randomized, Double-Blind, Parallel Group Phase 3 Study","authors":"R. Chen, L. Wei, Y. Dai, Z. Wang, D. Yang, M. Jin, C. Xiong, T. Li, S. Hu, J. Song, N. Day, R. Chan, N. Zhong","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4766","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4766","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116409708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Influence of Administering Mepolizumab by Autoinjector on Real-world Outcomes in Severe Asthma: Results From the REALITI-A Study at 2 Years 自注射器给药Mepolizumab对严重哮喘患者实际预后的影响:来自REALITI-A研究2年的结果
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4746
M. Liu, C. Pilette, D. Bagnasco, M. T. Audicana Berasategui, A. Smith, R. Price, L. Demetriou, D. Hill, P. Howarth
{"title":"The Influence of Administering Mepolizumab by Autoinjector on Real-world Outcomes in Severe Asthma: Results From the REALITI-A Study at 2 Years","authors":"M. Liu, C. Pilette, D. Bagnasco, M. T. Audicana Berasategui, A. Smith, R. Price, L. Demetriou, D. Hill, P. Howarth","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4746","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4746","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124776560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of 蠅1, 蠅2, or 蠅3 Prior Exacerbations: Liberty Asthma Traverse Dupilumab降低了中度至重度哮喘患者的严重加重率并改善了支气管扩张剂前Fev1，无论其先前的加重史有1、2或3次加重:自由哮喘穿越
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742
J. Maspero, J. Corren, C. Katelaris, M. Castro, M.J.C. Humbert, D. Halpin, A. Altincatal, N. Pandit-Abid, X. Soler, A. Radwan, J. Jacob-Nara, Y. Deniz, P. Rowe
{"title":"Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of 蠅1, 蠅2, or 蠅3 Prior Exacerbations: Liberty Asthma Traverse","authors":"J. Maspero, J. Corren, C. Katelaris, M. Castro, M.J.C. Humbert, D. Halpin, A. Altincatal, N. Pandit-Abid, X. Soler, A. Radwan, J. Jacob-Nara, Y. Deniz, P. Rowe","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"28 9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122852799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study Tezepelumab在重度未控制哮喘患者中的疗效:来自3期导航研究的结果
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4751
M. Kraft, G. Chupp, K. Reeh, A. Lindsley, B. Cook, G. Hunter, C. Ambrose
{"title":"Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma by Sex: Results From the Phase 3 Navigator Study","authors":"M. Kraft, G. Chupp, K. Reeh, A. Lindsley, B. Cook, G. Hunter, C. Ambrose","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4751","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4751","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127940441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Eosinophil and IgE Levels at Initiation of Biologics for the Treatment of Severe Asthma, a Perspective From US, EU-4, and UK 从美国、欧盟和英国的角度来看，治疗严重哮喘的生物制剂开始时的血液嗜酸性粒细胞和IgE水平
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4755
S. Valliant, J. Harvey, S. Zhang, G. Mu, R. Jakes, K. Emeanuru, K. Brunini Pitta Palhares, M. Andre, R. Alfonso Cristancho
{"title":"Blood Eosinophil and IgE Levels at Initiation of Biologics for the Treatment of Severe Asthma, a Perspective From US, EU-4, and UK","authors":"S. Valliant, J. Harvey, S. Zhang, G. Mu, R. Jakes, K. Emeanuru, K. Brunini Pitta Palhares, M. Andre, R. Alfonso Cristancho","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4755","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4755","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123561057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Month-to-Month Real-World Patterns of Inhaler Use in Patients With Controlled and Uncontrolled Severe Asthma Treated With Biologics 使用生物制剂治疗的受控和非受控严重哮喘患者吸入器使用的逐月真实世界模式
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4757
A. Mohan, B. Derstine, A. Boe, T. Hill, S. Wang, P. Zhang, M. Gulati, E. Shoemaker, R. Esparza, H. Harwood, N. Lugogo
{"title":"Month-to-Month Real-World Patterns of Inhaler Use in Patients With Controlled and Uncontrolled Severe Asthma Treated With Biologics","authors":"A. Mohan, B. Derstine, A. Boe, T. Hill, S. Wang, P. Zhang, M. Gulati, E. Shoemaker, R. Esparza, H. Harwood, N. Lugogo","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4757","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4757","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116900493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Dupilumab in Patients From China With Persistent Asthma: A Subgroup Analysis of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study Dupilumab在中国持续性哮喘患者中的疗效和安全性:一项随机、双盲、安慰剂对照、平行组、3期研究的亚组分析
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4768
Q. Zhang, N. Zhong, H. Fang, S. Zhu, Z. Wang, L. Zhao, E. Laws, L. Mannent, Y. Wang, V. Li, A. Li, C.‐C. Hu, D. Lederer, R. Abdulai, L. Robinson
{"title":"Efficacy and Safety of Dupilumab in Patients From China With Persistent Asthma: A Subgroup Analysis of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study","authors":"Q. Zhang, N. Zhong, H. Fang, S. Zhu, Z. Wang, L. Zhao, E. Laws, L. Mannent, Y. Wang, V. Li, A. Li, C.‐C. Hu, D. Lederer, R. Abdulai, L. Robinson","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4768","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4768","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124823481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world Effectiveness of Dupilumab in Biologic Naïve Patients With Asthma: Analysis From the US Advantage Study 杜匹单抗在Naïve哮喘患者中的实际疗效:来自美国优势研究的分析
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4743
R. Stanford, M. Blaiss, E. Bleecker, J. Jacob-Nara, M. Duh, Z. Wang, X. Soler, M. Hardin, M. Ye, R. Nair
{"title":"Real-world Effectiveness of Dupilumab in Biologic Naïve Patients With Asthma: Analysis From the US Advantage Study","authors":"R. Stanford, M. Blaiss, E. Bleecker, J. Jacob-Nara, M. Duh, Z. Wang, X. Soler, M. Hardin, M. Ye, R. Nair","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4743","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4743","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125555785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Remission and Associated Reductions in Background Medication in Patients With Severe Asthma: An Analysis of the Phase 3b ANDHI in Practice Substudy 重度哮喘患者的临床缓解和相关的背景药物减少:对3b期ANDHI临床亚研究的分析
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4756
T. Harrison, R. Louis, J. Kwiatek, A. Shavit, E. Genofre, D. Cohen, N. Keeling, B. Cosío
{"title":"Clinical Remission and Associated Reductions in Background Medication in Patients With Severe Asthma: An Analysis of the Phase 3b ANDHI in Practice Substudy","authors":"T. Harrison, R. Louis, J. Kwiatek, A. Shavit, E. Genofre, D. Cohen, N. Keeling, B. Cosío","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4756","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4756","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"82 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121291603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Real-World Study to Evaluate the Effectiveness of Mepolizumab in Treating Severe Asthma in Taiwan (REMIT) Mepolizumab治疗台湾重度哮喘的临床研究(REMIT)
C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4745
X. Xu, Diang-Wang Perng, S.-L. Cheng, Yih-tsen Lai, D. Milea
{"title":"A Real-World Study to Evaluate the Effectiveness of Mepolizumab in Treating Severe Asthma in Taiwan (REMIT)","authors":"X. Xu, Diang-Wang Perng, S.-L. Cheng, Yih-tsen Lai, D. Milea","doi":"10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4745","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4745","url":null,"abstract":"","PeriodicalId":222112,"journal":{"name":"C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114251718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信